Milestone marks transition of Pyxis Oncology to a clinical-stage company . Preliminary data anticipated in early 2024. CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today …Pyxis Oncology ( NASDAQ: PYXS) is a biotech based in Cambridge, Massachusetts, with two therapeutics in the clinic that have potential in various cancer types. The stock reached a recent low in ...Pyxis Oncology. stock last closed at $3.68, down 0.81% from the previous day, and has increased 125.77% in one year. It has overperformed other stocks in the Biotechnology industry by 1.62 percentage points. Pyxis Oncology stock is currently +172.59% from its 52-week low of $1.35, and -46.82% from its 52-week high of $6.92.RBC Capital Markets. Leonid Timashev. William Blair. Andy Hsieh. Pyxis Oncology is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Pyxis Oncology's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pyxis Oncology or its management.The transportation company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.07. The transportation company had revenue of $11.10 million for the quarter. Pyxis Tankers had a net margin of 43.32% and a trailing twelve-month return on equity of 30.88%.Information on stock, financials, earnings, subsidiaries, investors, and executives for Pyxis Oncology. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Pyxis Oncology. ... Pyxis Oncology Stock Performance (As of Friday Closing) Stock Price Previous ...On September 13, 2023, Lara Sullivan, President and CEO of Pyxis Oncology Inc (NASDAQ:PYXS), sold 27,917 shares of the company. TipRanks Pyxis Stock Is Up 170% This Week. The Investor Relations website contains information about Pyxis Oncology's business for stockholders, potential investors, and financial analysts. ... Pyxis Oncology …Feb 17, 2024 · What is the target price for Pyxis Oncology (PYXS) stock? The latest price target for Pyxis Oncology ( NASDAQ: PYXS) was reported by BTIG on Friday, February 9, 2024. The analyst firm set a price ... Feb 16, 2024 · The 12-month stock price forecast is $10.0, which is an increase of 83.49% from the latest price. Price Target $10.0 ( 83.49% upside) Analyst Consensus: Strong Buy Stock Forecasts News All Videos Press Releases Conversation Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Oct 4, 2021 ... Update: Pyxis on October 7, announced the pricing of its upsized initial public offering of 10,500,000 shares of common stock at an initial ...The latest Pyxis Oncology stock prices, stock quotes, news, and PYXS history to help you invest and trade smarter. ... On Friday 02/16/2024 the closing price of the Pyxis Oncology Inc Registered ... View Pyxis Oncology, Inc PYXS investment & stock information. Get the latest Pyxis Oncology, Inc PYXS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.3 days ago ... ... price target which is more positive news for Pyxis Oncology. The firm also highlighted the stock as a pure-play ADC. ProShares Ultra NASDAQ ...Feb 12, 2024 · Get Pyxis Oncology Inc (PYXS.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Oct-07-21 10:24PM. Pyxis Announces Pricing of Upsized Initial Public Offering. (GlobeNewswire) Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis Oncology, Inc. Common Stock (PYXS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Pyxis Oncology Inc (NASDAQ:PYXS) Intrinsic Valuation. Check if PYXS is overvalued or undervalued under the bear, base, and bull scenarios of the company's future. ... Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal ...Interactive stock price chart for Pyxis Oncology, Inc. (PYXS) with real-time updates, full price history, technical analysis and more. ... Pyxis Oncology, Inc. (PYXS) NASDAQ: PYXS · IEX Real-Time Price · USD. Add to Watchlist 5.45-0.14 (-2.50%) At close: Feb 16, 2024, 4:00 PM. 5.40Significantly high institutional ownership implies Pyxis Oncology's stock price is sensitive to their trading actions. A total of 5 investors have a majority stake in the company with 52% ownership.View Pyxis Oncology, Inc PYXS investment & stock information. Get the latest Pyxis Oncology, Inc PYXS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.PYXS's current price target is $9.00. Learn why top analysts are making this stock forecast for Pyxis Oncology at MarketBeat.Find the latest analyst research for Pyxis Oncology, Inc. Common Stock (PYXS) at Nasdaq.com.NASDAQ:PYXS Pyxis Oncology (PYXS) Stock Price, News & Analysis $4.29 +0.58 (+15.63%) (As of 12:58 PM ET) Compare Today's Range $3.82 $4.54 50-Day …With Pyxis Oncology stock trading at $3.16 per share, the total value of Pyxis Oncology stock (market capitalization) is $140.06M. Pyxis Oncology stock was originally listed at a price of $13.20 in Oct 8, 2021.Pyxis Oncology, Inc. Stock price Equities PYXS US7473241013 Biotechnology & Medical ResearchStock Price Forecast. The 6 analysts with 12-month price forecasts for Pyxis Oncology stock have an average target of 10, with a low estimate of 4.00 and a high ...Pelosi purchased 10,000 shares of Disney in January 2022 by exercising 100 Disney call options with a strike price of $100. In September 2022, Pelosi reported that 50 Disney call options she ...On Friday, BTIG initiated coverage on Pyxis Oncology Inc. (NASDAQ:PYXS) with a Buy rating and a price target of $8.00. The firm highlighted Pyxis's status as a pure-play antibody-drug conjugate (ADC) company with a proprietary technology platform that has evolved from over a decade of ADC innovation at Pfizer (NYSE: PFE ).Pfizer holds …Discover the latest data for Pyxis Oncology financials. From earnings and revenue to ROE, net margins, growth rates and more. ... Subscribe for free today! Dashboard Markets Discover Watchlist Portfolios Screener. Pyxis Oncology, Inc. NasdaqGS:PYXS Stock Report. Market Cap: US$217.5m. Add to watchlist. Company Overview; 1 Valuation; 2 …Pyxis Oncology ( NASDAQ: PYXS) is a biotech based in Cambridge, Massachusetts, with two therapeutics in the clinic that have potential in various cancer types. The stock reached a recent low in ...Biotech stock Pyxis Oncology (NASDAQ:PYXS) managed to achieve a serious milestone today.It hit a high not seen in 11 months, and it’s all thanks to an unexpected source of support. That support is none other than Pfizer (), and it’s helped Pyxis blast up over 48% in Tuesday’s trading session.Trading volume on Pyxis shares was brisk, reaching above …The Pyxis Oncology, Inc. stock forecast for tomorrow is $ 4.93, which would represent a 0.41% gain compared to the current price. In the next week, the price of PYXS is expected to decrease by -37.72% and hit $ 3.06.. As far as the long-term Pyxis Oncology, Inc. stock forecast is concerned, here’s what our predictions are currently suggesting.Pyxis Oncology Inc (NASDAQ: PYXS) agreed to acquire Apexigen Inc (NASDAQ: APGN) in an all-stock transaction for an implied value of $0.64 per Apexigen share. Apexigen went public in a blank-check ...William Blair restated an "outperform" rating on shares of Pyxis Oncology in a report on Wednesday, November 8th. Finally, HC Wainwright reaffirmed a "buy" rating and set a $4.00 target price on shares of Pyxis Oncology in a research report on Thursday, November 30th. Seven research analysts have rated the stock with a buy rating, Based …Complete Pyxis Oncology Inc. stock information by Barron's. View real-time PYXS stock price and news, along with industry-best analysis. As of March 21, 2023, the outstanding number of shares of Common Stock of Pyxis Oncology was 36,980,621. Pam Connealy , Chief Financial Officer of Pyxis Oncology , added, “As our clinical programs have advanced, our team has established a strong financial foundation with no debt and a cash runway into the first half of 2025.Dec 6, 2021 ... Pyxis Oncology (Nasdaq:PYXS) tumbled more than 20% Monday to a post-IPO low as the cancer-drug developer's stock apparently sank on a key ...On Friday, BTIG initiated coverage on Pyxis Oncology Inc. (NASDAQ:PYXS) with a Buy rating and a price target of $8.00. The firm highlighted Pyxis's status as a pure-play antibody-drug conjugate (ADC) company with a proprietary technology platform that has evolved from over a decade of ADC innovation at Pfizer (NYSE: PFE).Pfizer holds …Complete Pyxis Oncology Inc. stock information by Barron's. View real-time PYXS stock price and news, along with industry-best analysis. Information on stock, financials, earnings, subsidiaries, investors, and executives for Pyxis Oncology. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Pyxis Oncology. ... Pyxis Oncology Stock Performance (As of Friday Closing) Stock Price Previous ...Feb 7, 2024 ... Buy Pyxis Oncology (PYXS) Put Options ; $2.50, $0.25, $2.25, -71.00%, 0.00% ; $5.00, $1.95, $3.05, -26.00%, 0.00% ...As of 2024 February 10, Saturday current price of PYXS stock is 4.490$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). Pyxis Oncology stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. This results in Pyxis Oncology shareholders owning approximately 90 percent and Apexigen shareholders owning approximately 10 percent of the combined company’s common stock, assuming no exercise or settlement of the converted options, restricted stock units or warrants. Pyxis Oncology issued approximately 4.3 million shares of …2 days ago · Stock Price Forecast. The 6 analysts with 12-month price forecasts for Pyxis Oncology stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 114.59% from the current stock price of 4.66. Pyxis Oncology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Check the Pyxis Oncology, Inc. stock price today on the NASDAQ stock exchange and access historical PYXS stock price chart. Get the latest Pyxis Oncology, ...About Pyxis Oncology Inc. Full Ratings. 840.66K (222.60% of Avg) 65 Day Avg: 377.66K. 377.66K. Gilead Sciences Inc. Daiichi Sankyo Co. Ltd. Astellas Pharma Inc. Company & People Research & Ratings. Get a real-time Pyxis Oncology, Inc. (PYXS) stock price quote with breaking news, financials, statistics, charts and more.Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing. Nov 7, 2023 · Pyxis Oncology is devoted to transforming the lives of patients with cancer by advancing our innovative and differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies offer unique potential to address difficult-to-treat cancers ... The Pyxis Oncology, Inc. stock prediction for 2025 is currently $ 4.05, assuming that Pyxis Oncology, Inc. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -17.42% increase in the PYXS stock price. Pyxis Oncology, Inc. Stock Prediction 2030 3 days ago ... ... price target which is more positive news for Pyxis Oncology. The firm also highlighted the stock as a pure-play ADC. ProShares Ultra NASDAQ ...On August 23, 2023, Pyxis Oncology announced the successful completion of its acquisition of Apexigen, Inc., in an all-stock transaction valued at approximately $10.7 million. Opportunity to advance clinical development of sotigalimab (which Pyxis Oncology has renamed PYX-107) will be further assessed as part of portfolio evaluation following …This is Pyxis Oncology, Inc.'s initial public offering. We are selling shares of our common stock. We expect the public offering price to be between $ and $ per ...The current price Pyxis Oncology ( PYXS) is trading at is $4.47, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Analysts publish ratings ... This results in Pyxis Oncology shareholders owning approximately 90 percent and Apexigen shareholders owning approximately 10 percent of the combined company’s common stock, assuming no exercise or settlement of the converted options, restricted stock units or warrants. Pyxis Oncology issued approximately 4.3 million shares of …The Pyxis Oncology, Inc. stock forecast for tomorrow is $ 4.93, which would represent a 0.41% gain compared to the current price. In the next week, the price of PYXS is expected to decrease by -37.72% and hit $ 3.06.. As far as the long-term Pyxis Oncology, Inc. stock forecast is concerned, here’s what our predictions are currently suggesting.The Pyxis Oncology, Inc. stock prediction for 2025 is currently $ 4.05, assuming that Pyxis Oncology, Inc. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -17.42% increase in the PYXS stock price. Pyxis Oncology, Inc. Stock Prediction 2030 Apr 17, 2022 ... View live Pyxis Oncology, Inc. chart to track its stock's price action. Find market predictions, PYXS financials and market news.Jun 30, 2023 · Get real-time Pyxis Oncology (PYXS) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing. Get the tools used by (smart) 2 investors. Pfizer-backed Pyxis hits 52-week high to cross $200M market cap. Pyxis Oncology ( NASDAQ: PYXS) shares reached a new 52-week high as the clinical-stage biotech backed by pharma giant Pfizer ( PFE ...The Pyxis Oncology, Inc. stock forecast for tomorrow is $ 4.93, which would represent a 0.41% gain compared to the current price. In the next week, the price of PYXS is expected to decrease by -37.72% and hit $ 3.06.. As far as the long-term Pyxis Oncology, Inc. stock forecast is concerned, here’s what our predictions are currently suggesting.Discover the latest data for Pyxis Oncology financials. From earnings and revenue to ROE, net margins, growth rates and more. ... Subscribe for free today! Dashboard Markets Discover Watchlist Portfolios Screener. Pyxis Oncology, Inc. NasdaqGS:PYXS Stock Report. Market Cap: US$217.5m. Add to watchlist. Company Overview; 1 Valuation; 2 …Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize...Pyxis Oncology, Inc.'s stock symbol is PYXS and currently trades under NASDAQ. It's current price per share is approximately $4.51.About Pyxis Oncology Inc. Full Ratings. 840.66K (222.60% of Avg) 65 Day Avg: 377.66K. 377.66K. Gilead Sciences Inc. Daiichi Sankyo Co. Ltd. Astellas Pharma Inc. Company & People Research & Ratings.Stock Quote & Chart; Historical Price Lookup; Investment Calculator; Analyst Coverage; Shareholder Services Menu Toggle. Investor FAQs; ... and those discussed in the section titled “Risk Factors” set forth in Pyxis Oncology’s Annual Report on Form 10-K for the year ended December 31, 2022, Pyxis Oncology’s Quarterly Report on Form 10-Q ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Cash runway extended to early 2026 due to cost reductions and portfolio prioritization, allows for preliminary data readouts from PYX-201 and PYX-106. Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing. Milestone marks transition of Pyxis Oncology to a clinical-stage company Preliminary data anticipated in early 2024 CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc ...Feb 16, 2024 ... Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS). Via ...Pyxis Oncology ( PYXS) reported Q3 2023 earnings per share (EPS) of -$0.56, missing estimates of -$0.51 by 10.02%. In the same quarter last year, Pyxis Oncology 's earnings per share (EPS) was -$0.85. Pyxis Oncology is expected to release next earnings on 03/21/2024, with an earnings per share (EPS) estimate of -$0.47. quantity. The Pyxis Oncology, Inc. stock price gained 5.10% on the last trading day (Thursday, 22nd Feb 2024), rising from $4.51 to $4.74. During the last trading day the stock fluctuated 8.72% from a day low at $4.49 to a day high of $4.88. The price has been going up and down for this period, and there has been a 25.56% gain for the last 2 weeks.Feb 17, 2024 · What is the target price for Pyxis Oncology (PYXS) stock? The latest price target for Pyxis Oncology ( NASDAQ: PYXS) was reported by BTIG on Friday, February 9, 2024. The analyst firm set a price ... This results in Pyxis Oncology shareholders owning approximately 90 percent and Apexigen shareholders owning approximately 10 percent of the combined company’s common stock, assuming no exercise or settlement of the converted options, restricted stock units or warrants. Pyxis Oncology issued approximately 4.3 million shares of common stock as ... Pyxis Oncology. stock last closed at $3.68, down 0.81% from the previous day, and has increased 125.77% in one year. It has overperformed other stocks in the Biotechnology industry by 1.62 percentage points. Pyxis Oncology stock is currently +172.59% from its 52-week low of $1.35, and -46.82% from its 52-week high of $6.92.Complete Pyxis Oncology Inc. stock information by Barron's. View real-time PYXS stock price and news, along with industry-best analysis. Closing Price Volume Split Adjustment Factor Open Price Day High Day Low; Jan 22, 2024: $2.55: 372,627: 1:1: $2.35: ... Day's High, Day's Low, and Day's …3 days ago · 8 brokerages have issued 1 year price objectives for Pyxis Oncology's stock. Their PYXS share price targets range from $4.00 to $14.00. On average, they expect the company's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 90.7% from the stock's current price. View analysts price targets for PYXS or view ... Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... PYXS - Pyxis ... Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing. Nov 7, 2023 ... As of September 30, 2023, the outstanding number of shares of common stock of Pyxis Oncology was 44,294,092. ... What is the ticker symbol of ...Nov 7, 2023 · Pyxis Oncology is devoted to transforming the lives of patients with cancer by advancing our innovative and differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies offer unique potential to address difficult-to-treat cancers ... For each share of Apexigen, Pyxis Oncology will issue 0.1725 shares of its common stock, par value $0.001 per share, for a total enterprise value of approximately $16 million. Apexigen, Inc. Price ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...
3 days ago ... ... price target which is more positive news for Pyxis Oncology. The firm also highlighted the stock as a pure-play ADC. ProShares Ultra NASDAQ .... How to kiss a girl
On September 13, 2023, Lara Sullivan, President and CEO of Pyxis Oncology Inc (NASDAQ:PYXS), sold 27,917 shares of the company. TipRanks Pyxis Stock Is Up 170% This Week. Pyxis Oncology Stock. Pyxis Oncology builds a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies, to improve the lives of patients with difficult-to-treat cancers. Pyxis Oncology completed their IPO on October 8, 2021 to list on NASDAQ with ticker PYXS at an implied valuation of $530.55MM.Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs. First subject dosed in Phase 1 trial of PYX-106, a fully human immunotherapy antibody candidate. Second dose level initiated in Phase 1 trial of PYX-201, an antibody-drug conjugate (ADC) candidate. Preliminary data from both trials on track for late-2023/early-2024 timeframe.Stock Price & Overview $4.86 -0.59 ( -10.83%) 3:52 PM 02/20/24 NASDAQ | $USD | Realtime Summary Ratings Financials Earnings Dividends Valuation Growth …On September 13, 2023, Lara Sullivan, President and CEO of Pyxis Oncology Inc (NASDAQ:PYXS), sold 27,917 shares of the company. TipRanks Pyxis Stock Is Up 170% This Week. (NASDAQ: PYXS) Pyxis Oncology stock price per share is $4.86 today (as of Feb 23, 2024). What is Pyxis Oncology's Market Cap ...Cash runway extended to early 2026 due to cost reductions and portfolio prioritization, allows for preliminary data readouts from PYX-201 and PYX-106. Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing. Agreement and Plan of Merger, dated May 23, 2023, by and among Pyxis Oncology, Inc., Ascent Merger Sub Corp., and Apexigen, Inc. (attached as Annex A to the proxy statement/prospectus which forms part of this registration statement and previously filed with Pyxis Oncology’s Current Report on Form 8-K, filed with the SEC on May 24, 2023). 05 ...Feb 17, 2024 · What is the target price for Pyxis Oncology (PYXS) stock? The latest price target for Pyxis Oncology ( NASDAQ: PYXS) was reported by BTIG on Friday, February 9, 2024. The analyst firm set a price ... Jun 30, 2023 · 321 Harrison Avenue 11 th Floor, Suite 1 Boston, MA 02118 (617) 453-3596 | [email protected] Track Pyxis Oncology Inc (PYXS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors .